SE9103110D0 - New drug formulation - Google Patents

New drug formulation

Info

Publication number
SE9103110D0
SE9103110D0 SE9103110A SE9103110A SE9103110D0 SE 9103110 D0 SE9103110 D0 SE 9103110D0 SE 9103110 A SE9103110 A SE 9103110A SE 9103110 A SE9103110 A SE 9103110A SE 9103110 D0 SE9103110 D0 SE 9103110D0
Authority
SE
Sweden
Prior art keywords
pct
ion
drug
ion exchanger
substance
Prior art date
Application number
SE9103110A
Other languages
English (en)
Inventor
G A Ragnarsson
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Priority to SE9103110A priority Critical patent/SE9103110D0/sv
Publication of SE9103110D0 publication Critical patent/SE9103110D0/sv
Priority to NZ244516A priority patent/NZ244516A/en
Priority to ZA927506A priority patent/ZA927506B/xx
Priority to AU28898/92A priority patent/AU666887B2/en
Priority to US08/211,863 priority patent/US5643560A/en
Priority to PCT/SE1992/000724 priority patent/WO1993007860A1/en
Priority to JP5507642A priority patent/JPH07500332A/ja
Priority to CA002122034A priority patent/CA2122034A1/en
Priority to EP92922699A priority patent/EP0610351A1/en
Priority to PT100998A priority patent/PT100998A/pt
Priority to NO941479A priority patent/NO941479D0/no
Priority to FI941878A priority patent/FI941878A/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
SE9103110A 1991-10-24 1991-10-24 New drug formulation SE9103110D0 (sv)

Priority Applications (12)

Application Number Priority Date Filing Date Title
SE9103110A SE9103110D0 (sv) 1991-10-24 1991-10-24 New drug formulation
NZ244516A NZ244516A (en) 1991-10-24 1992-09-28 Pharmaceutical composition containing a psychotropic drug complexed to ion-exchange material
ZA927506A ZA927506B (en) 1991-10-24 1992-09-30 New drug formulation.
EP92922699A EP0610351A1 (en) 1991-10-24 1992-10-16 New drug formulations with ion-exchangers
US08/211,863 US5643560A (en) 1991-10-24 1992-10-16 Drug formulation with ion-exchangers
AU28898/92A AU666887B2 (en) 1991-10-24 1992-10-16 New drug formulations with ion-exchangers
PCT/SE1992/000724 WO1993007860A1 (en) 1991-10-24 1992-10-16 New drug formulations with ion-exchangers
JP5507642A JPH07500332A (ja) 1991-10-24 1992-10-16 イオン交換体を有する新規な薬剤
CA002122034A CA2122034A1 (en) 1991-10-24 1992-10-16 New drug formulations with ion-exchangers
PT100998A PT100998A (pt) 1991-10-24 1992-10-22 Formulacoes farmaceuticas a base de um ou varios farmacos psicotropicos, nomeadamente, agentes antidepressivos triciclicos ou tetraciclicos com a funcao amina, complexados com permutadores de ioes, sua utilizacao e processo de preparacao
NO941479A NO941479D0 (no) 1991-10-24 1994-04-22 Nye legemiddelformuleringer inneholdende ionebyttere
FI941878A FI941878A (sv) 1991-10-24 1994-04-22 Nya till jonbytarer kopplade läkemedelspreparater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9103110A SE9103110D0 (sv) 1991-10-24 1991-10-24 New drug formulation

Publications (1)

Publication Number Publication Date
SE9103110D0 true SE9103110D0 (sv) 1991-10-24

Family

ID=20384104

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9103110A SE9103110D0 (sv) 1991-10-24 1991-10-24 New drug formulation

Country Status (12)

Country Link
US (1) US5643560A (sv)
EP (1) EP0610351A1 (sv)
JP (1) JPH07500332A (sv)
AU (1) AU666887B2 (sv)
CA (1) CA2122034A1 (sv)
FI (1) FI941878A (sv)
NO (1) NO941479D0 (sv)
NZ (1) NZ244516A (sv)
PT (1) PT100998A (sv)
SE (1) SE9103110D0 (sv)
WO (1) WO1993007860A1 (sv)
ZA (1) ZA927506B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3346680B2 (ja) * 1995-05-11 2002-11-18 株式会社西部技研 湿気交換用吸着体
SE9702793D0 (sv) * 1997-07-24 1997-07-24 Astra Pharma Prod Novel formulation
IT1297461B1 (it) 1997-10-29 1999-12-17 Ciocca Maurizio Preparazione di compresse a rilascio controllato a base di complessi tra carragenano e farmaci basici solubili
WO2003020242A1 (en) * 2001-08-29 2003-03-13 Srl Technologies, Inc. Sustained release preparations
EP1679962B1 (en) * 2003-10-20 2021-01-13 Framework Therapeutics, L.L.C. Zeolite molecular sieves for the removal of toxins
EP1926736A4 (en) * 2005-09-21 2010-08-25 Chong Kun Dang Pharm Corp NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF
US20100273822A1 (en) * 2009-04-22 2010-10-28 William Wayne Howard Immediate release compositions and methods for delivering drug formulations using strong acid ion exchange resins
JP6577024B2 (ja) * 2014-05-08 2019-09-18 シーティーシー バイオ インコーポレイテッド 味が遮蔽されたクロミプラミン含有経口投与用薬学製剤
CA2910865C (en) 2014-07-15 2016-11-29 Isa Odidi Compositions and methods for reducing overdose

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2697059A (en) * 1951-01-22 1954-12-14 Edwin L Gustus Hydroxy aromatic carboxylate-resin adsorption composition
US2990332A (en) * 1958-04-02 1961-06-27 Wallace & Tiernan Inc Pharmaceutical preparations comprising cation exchange resin adsorption compounds and treatment therewith
US3131121A (en) * 1960-10-31 1964-04-28 Hoffmann La Roche Highly acidic cation exchange resin containing amprotropine cations
GB1176194A (en) 1967-08-12 1970-01-01 Geigy Uk Ltd Pharmaceutical Compositions
FR1568046A (sv) * 1968-01-19 1969-05-23
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
LU63060A1 (sv) * 1971-04-26 1971-08-26
US4221778A (en) * 1979-01-08 1980-09-09 Pennwalt Corporation Prolonged release pharmaceutical preparations
DE3234458A1 (de) 1982-04-01 1983-10-13 Sanimed Vertrieb AG, St. Gallen, 9000 St. Gallen Staugurt
AU565487B2 (en) 1983-09-16 1987-09-17 Fisons Corporation Liquid prolonged release pharmaceutical formulations containing ionic constituents
DK110188D0 (da) * 1988-03-02 1988-03-02 Claus Selch Larsen High molecular weight prodrug derivatives of antiinflammatory drugs
US4996047A (en) * 1988-11-02 1991-02-26 Richardson-Vicks, Inc. Sustained release drug-resin complexes
CA2002492A1 (en) * 1988-11-11 1990-05-11 Sandra T. A. Malkowska Pharmaceutical ion exchange resin composition

Also Published As

Publication number Publication date
FI941878A0 (sv) 1994-04-22
US5643560A (en) 1997-07-01
ZA927506B (en) 1993-05-03
NZ244516A (en) 1995-07-26
CA2122034A1 (en) 1993-04-29
FI941878A (sv) 1994-06-22
AU2889892A (en) 1993-05-21
NO941479L (sv) 1994-06-23
WO1993007860A1 (en) 1993-04-29
EP0610351A1 (en) 1994-08-17
PT100998A (pt) 1994-01-31
NO941479D0 (no) 1994-04-22
AU666887B2 (en) 1996-02-29
JPH07500332A (ja) 1995-01-12

Similar Documents

Publication Publication Date Title
NO952321D0 (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
BR9810984A (pt) Composto de triazol, uso do mesmo, e, composição farmacêutica
GB9126209D0 (en) Drug formulations for parenteral use
ATE159526T1 (de) Meso-tetraphenylporphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
IL100015A0 (en) Mono-n-substituted 1,4,7,10-tetraazacyclododecane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
FI972287A (sv) Nya polysubstituerade DTPA-derivat och deras metallkomplexer, dessa komplexer innehållande farmaceutiska ämnen deras användning i diagnostik och terapi samt förfaranden för framställning av dessa komplexbildare och komplexer och förfaranden för framställning av dessa.............
PL324890A1 (en) Halogenbenzimidazoles and their application as microbicides
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
ES2126661T3 (es) Pirazoles que tienen actividad antagonista de crf.
DE69225484D1 (de) Gallium iii komplexe, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten
SE9103110D0 (sv) New drug formulation
Barltrop Lead poisoning in childhood.
CA2311024C (en) Pharmaceutical composition for oral administration of chelating agents
ATE153342T1 (de) Adenosinderivate, verfahren zu deren herstellung und pharmazeutische mittel
AU1300383A (en) Amides useful in the treatment of diabetes
ES2090703T3 (es) Medicamento agudo que contiene flurbiprofeno y su empleo.
KR970061248A (ko) 알츠하이머병 치료용 1, 1, 2-트리페닐부트-1-엔 유도체
JPS57146723A (en) Pharmaceutical preparation having improved absorption
KR980002033A (ko) 트리아졸 유도체 또는 그 염
SI0863752T1 (en) Use of allylamine derivatives such as terbinafine, in the manufacture of a medicament for the treatment of helicobacter pylori infection of associated diseases
NO20001812D0 (no) Gallesyresalter av metaller med fysiologisk virkning, samt terapeutisk anvendelse derav
KR900017599A (ko) 종양 치료용 약학 조성물
NO970140L (no) Technetium-sulfonamidkomplekser, deres anvendelse, farmasöytiske midler inneholdende disse, samt fremgangsmåte for fremstilling av kompleksene og midlene
JPS59210040A (ja) ヒノキチオ−ルの安定化法